Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Clinical trial NCT05102448 · RECRUITING

Trial details

NCT number: NCT05102448
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Takayasu Arteritis

Start date: 2021-11-01
Primary completion: 2025-12-31
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.